Management of new-onset postoperative atrial fibrillation after coronary artery bypass grafting

Current evidence suggests that POAF functions more as an indicator of underlying patient vulnerability than as a direct driver of adverse outcomes. Clinically, management must balance arrhythmia control, stroke and bleeding risk, and individualized anticoagulation decisions. Research efforts should prioritize robust risk stratification tools and randomized evidence to guide tailored therapy.